Literature DB >> 15255944

Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD-95.

Michaela Soltau1, Kerstin Berhörster, Stefan Kindler, Fritz Buck, Dietmar Richter, Hans-Jürgen Kreienkamp.   

Abstract

The insulin receptor substrate of 53 kDa (IRSp53) is a target of the small GTPase cdc42 which is strongly enriched in the postsynaptic density of excitatory synapses. IRSp53 interacts with the postsynaptic shank1 scaffolding molecule in a cdc42 regulated manner. The functional significance of the cdc42/IRSp53 pathway in postsynaptic sites is however, unclear. Here we identify PSD-95 as a second synaptic interaction partner of IRSp53. Interaction is mediated by a C-terminal PDZ binding motif in IRSp53 and the second PDZ domain of PSD-95. In HEK cells, overexpressed IRSp53 induces filopodia and targets PSD-95 into these processes. Immunoprecipitation and immunocytochemistry experiments demonstrate that the interaction occurs at postsynaptic sites in the brain. By virtue of its PDZ-binding and SH3 domains, IRSp53 is capable of inducing the formation of a triple complex (shank1/IRSp53/PSD-95).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255944     DOI: 10.1111/j.1471-4159.2004.02523.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  39 in total

1.  Characterization of Staufen 1 ribonucleoprotein complexes.

Authors:  Cornelia Brendel; Monika Rehbein; Hans-Jürgen Kreienkamp; Friedrich Buck; Dietmar Richter; Stefan Kindler
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  The magic of synaptogenesis. Meeting on spinogenesis and synaptic plasticity.

Authors:  Hans-Jürgen Kreienkamp; Alexander Dityatev
Journal:  EMBO Rep       Date:  2004-12       Impact factor: 8.807

3.  Structural basis for the actin-binding function of missing-in-metastasis.

Authors:  Sung Haeng Lee; Frederic Kerff; David Chereau; François Ferron; Alexandra Klug; Roberto Dominguez
Journal:  Structure       Date:  2007-02       Impact factor: 5.006

Review 4.  MAGUKs, synaptic development, and synaptic plasticity.

Authors:  Chan-Ying Zheng; Gail K Seabold; Martin Horak; Ronald S Petralia
Journal:  Neuroscientist       Date:  2011-04-15       Impact factor: 7.519

Review 5.  Morphogenic signaling in neurons via neurotransmitter receptors and small GTPases.

Authors:  Evgeni Ponimaskin; Tatyana Voyno-Yasenetskaya; Diethelm W Richter; Melitta Schachner; Alexander Dityatev
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

6.  Preso, a novel PSD-95-interacting FERM and PDZ domain protein that regulates dendritic spine morphogenesis.

Authors:  Hyun Woo Lee; Jeonghoon Choi; Hyewon Shin; Karam Kim; Jinhee Yang; Moonseok Na; So Yoen Choi; Gil Bu Kang; Soo Hyun Eom; Hyun Kim; Eunjoon Kim
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

7.  Regulation of IRSp53-dependent filopodial dynamics by antagonism between 14-3-3 binding and SH3-mediated localization.

Authors:  Jeffrey M Robens; Lee Yeow-Fong; Elsa Ng; Christine Hall; Ed Manser
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

8.  A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.

Authors:  Cendrine Tourette; Biao Li; Russell Bell; Shannon O'Hare; Linda S Kaltenbach; Sean D Mooney; Robert E Hughes
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

9.  Mechanism of IRSp53 inhibition and combinatorial activation by Cdc42 and downstream effectors.

Authors:  David J Kast; Changsong Yang; Andrea Disanza; Malgorzata Boczkowska; Yadaiah Madasu; Giorgio Scita; Tatyana Svitkina; Roberto Dominguez
Journal:  Nat Struct Mol Biol       Date:  2014-03-02       Impact factor: 15.369

10.  NMDA receptor-dependent synaptic translocation of insulin receptor substrate p53 via protein kinase C signaling.

Authors:  Kei Hori; Hiroki Yasuda; Daijiro Konno; Hisato Maruoka; Tadaharu Tsumoto; Kenji Sobue
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.